Featured
Who will bag the last PBS listings of 2026?
Twelve pharmas are jostline to score the last PBS listings for the year, from brand new drugs to new indications, with two companies vying to win two additions
Sales, Marketing & Public Relations
The best oncology drug launch in history?
A monster return after just five weeks on the market has led one analyst to dub the launch of this cancer drug, the GOAT
Regulatory & Reimbursement
Bayer, Besins Healthcare add new drugs
The TGA has approved a new treatment for contraception and endometriosis plus a new contrast agent for enhanced diagnostic imaging
Jobs & Workplace
Inside Aussie pharma's kindest workplace
Recently recertified as a Kind Company this company reveals how its ANZ team is embedding kindness into its everyday culture and beyond
Regulation & Legal
TGA cracks down on fake Lilly drug
The regulator has raised fresh concerns about fakes of Lilly's experimental weight loss drug, homing in on a specific branded counterfeit
Featured
New Aussie Country Manager named in reshuffle
This pharma has undergone significant leadership changes in recent months, both globally and locally, with an Australian Country Manager officially named
Industry & Companies
Vertex staff roll up their sleeves
For the 18th year running Vertex has undertaken its Global Week of Service with the Aussie team pitching in on a home improvement project
Industry & Companies
Who's stolen industry's digital innovation crown?
Ending a rival's two-year reign, this pharma has snatched the lead in digital innovation, praised for making AI an 'enterprise backbone'
Leadership & People
Industry body reboots, earning prestigious award
LifeSciences Australia went from wallowing in dire straits three years ago to clear sailing now, earning it a prestigious recognition for its stellar turnaround
Jobs & Workplace
Is Australia's pharma workforce at breaking point?
Redundancies have overstretched pharma workforces, with those who've managed to keep their jobs, taking on the workload of up to four employees
Patients
Advocacy until the very end: Her final fight for change
Caitlin Delaney, has passed away and true to her unwavering advocacy, she continued to fight for faster access to medicines, recording a message in her final hours
Leadership & People
Ex-Aussie GM lifts lid on job search
The Australian pharma job market is a journey for everyone, even Country Leaders, as this former boss has revealed
Pipeline & Intellectual Property
You snooze, you lose: Lilly gets the jump on a rival
Carving a new niche in sleep apnoea for its latest blockbuster, the company is set to make even further ground after strong results in a late-stage trial
Featured
Who's nabbed 10 PRIME Award nominations?
Company heads into the PRIME Awards next week as a finalist for a staggering 10 campaigns across four categories. This is how they did it...
Jobs & Workplace
Medical Directors tackle thorny questions on AI
Twenty Aussie industry leaders gathered for the inaugural Medical Directors Breakfast on AI in Sydney, to unpack how AI is reshaping their teams
Industry & Companies
Pharma spend on HCPs shrinks
Companies lowered the amount they spent on HCPs each month in the first half of 2026, with just two pharmas getting into seven figures
Regulatory & Reimbursement
PBAC preps for submission complexities
The Department has released guidance on how to use AI in PBAC submissions and established a rolling review of PBAC guidelines
Jobs
Featured
Scam headhunters targeting Aussie pharma execs
Scammers impersonating legitimate Big Pharma in-house recruiters are targeting Australian industry professionals with lucrative high-income roles as part of a money-making racket
Pipeline & Intellectual Property
That was fast: Celairis to pay $10.3M for first drug
In its first major deal just days after launching, Matt Zeller and Damian Clarke-Bruce's company has added an investigational one-time gene therapy to its pipeline
Leadership & People
Ex-CSL exec steps into CEO role
After eight-plus years with the Aussie giant, this industry leader has taken a CEO role at a biotech with big ambitions to transform precision medicine
Jobs & Workplace
Companies line up talent for 2027
There's been a wave of movement across Australian pharma with promotions, new hires, departures and even a retirement as a new year looms
Regulation & Legal
Novartis gene therapy hit by cancer fears
A theoretical side-effect of the gene therapy has appeared in practice, alarming patient networks around the world
Industry & Companies
Satchel puts blister pack recycling within reach
Consumer Healthcare Products Australia and its members have come together with Pharmacycle to take blister pack recycling to the next level
Sales, Marketing & Public Relations
New access model reshaping pharma
Direct-to-patient programs are considered "mission critical" according to a third of pharma professionals who believe it will transform access
Jobs & Workplace
Pharma urged to grow Aussie workforce
New report on the Australian clinical trials workforce reveals the same people are either being reshuffled or lost, while others struggle to crack the market
Pipeline & Intellectual Property
Supply setback extends shortage into 2027
A national shortage of this treatment is expected to continue into 2027 after the pharma confirmed an order, expected this month, is now “unlikely”
Industry & Companies
Was this Aussie pharma's Best Kept Secret?
A bombshell announcement from two industry high-flyers was kept completely under wraps despite multiple big-name organisations getting on board with the new pharma venture. And now, they've detailed a potentially market-disrupting business model for medicines access
Industry & Companies
Pharma sold at undisclosed price
An international private equity firm has reached an agreement to acquire this pharma, with plans to support its global growth ambitions
Patients
Riders pedal past fundraising target
Aussie BMS staffers have raised double their original goal for Rare Cancers Australia through an 18,000 kilometre, 15-day cycling event in Japan
- Other News Matt Zeller launches new Australian pharma
- Government & Policy Boosting PBS spending a political no-brainer
- Regulatory & Reimbursement New drugs flood the ARTG
- Industry & Companies Roche unveils new tech for high-throughput genomics
- Leadership & People Pfizer names permanent ANZ leader
- Sales, Marketing & Public Relations What doctors really want Reps to talk about
- Leadership & People Country boss adds new leadership hat
- Patients Omico names genomic profiling partners
- Pipeline & Intellectual Property Pharma signs its biggest ever milestones deal
- Regulatory & Reimbursement Drugs dropped from PBAC meeting